Advertisement

Tumor Biology

, Volume 37, Issue 6, pp 7315–7325 | Cite as

Γ-Ionizing radiation-induced activation of the EGFR–p38/ERK–STAT3/CREB-1–EMT pathway promotes the migration/invasion of non-small cell lung cancer cells and is inhibited by podophyllotoxin acetate

  • Jeong Hyun Cho
  • Wan Gi Hong
  • Yu-Jin Jung
  • Jaeseok Lee
  • Eunah Lee
  • Sang-Gu Hwang
  • Hong-Duck Um
  • Jong Kuk Park
Original Article

Abstract

Here, we report a new intracellular signaling pathway involved in γ-ionizing radiation (IR)-induced migration/invasion and show that podophyllotoxin acetate (PA) inhibits the IR-induced invasion and migration of A549 cells (a non-small cell lung cancer (NSCLC) cell line). Our results revealed that IR increased the invasion/migration of A549 cells, and this effect was decreased by 10 nM PA treatment. PA also inhibited the expressions/activities of matrix metalloprotase (MMP) -2, MMP-9, and vimentin, suggesting that PA could block the IR-induced epithelial-mesenchymal transition (EMT). The IR-induced increases in invasion/migration were associated with the activation of EGFR-AKT, and PA inhibited this effect. P38 and p44/42 ERK were also involved in IR-induced invasion/migration, and combined treatments with PA plus inhibitors of each MAPK synergistically blocked this invasion/migration. In terms of transcription factors (TFs), IR-induced increases in cyclic AMP response element-binding protein-1 (CREB-1) and signal transducer and activator of transcription 3 (STAT3) increased invasion/migration and EMT. PA also inhibited these transcription factors and then blocked IR-induced invasion/migration. Collectively, these results indicate that IR induces cancer cell invasion/migration by activating the EGFR–p38/ERK–CREB-1/STAT3–EMT pathway and that PA blocks this pathway to inhibit IR-induced invasion/migration.

Keywords

Radiation Podophyllotoxin acetate Invasion Migration NSCLC 

Notes

Acknowledgments

This work was supported by a grant from the Nuclear Research & Development Program of the National Research Foundation of Korea (NRF), which is funded by the Korean government (MEST; 2012M2A2A7010422), and by the Basic Science Research Program of the NRF (NRF-2014R1A1A2054985).

Compliance with ethical standards

Conflicts of interest

None

Supplementary material

13277_2015_4548_MOESM1_ESM.pptx (116 kb)
Supplementary Fig. 1 Gelatin zymography assay to detect activity of MMPs. Cells were treated with various combinations of IR, PA, SB (10 μM SB203580), PD (10 μM PD98059) and Gefinitib (10 μM), and gelatin zymography was used to detect the activities of MMP-2 a and -9 b. Representative data from triplicate experiments are shown. (PPTX 116 kb)
13277_2015_4548_MOESM2_ESM.pptx (147 kb)
Supplementary Fig. 2 Apoptotic cell death detection with PI uptake. IR increases invasion/migration by activating STAT3, and these effects are modulated by PA. Cells were treated with IR and C188-9 (10 μM), and apoptotic cell death was determined by PI-uptake assay. Representative data from triplicate experiments are shown. (PPTX 146 kb)
13277_2015_4548_MOESM3_ESM.pptx (153 kb)
Supplementary Fig. 3 Apoptotic cell death detection with PI uptake. IR increases invasion/migration by activating CREB-1, and these effects are modulated by PA. Cells were subjected to IR and treated with an inhibitor of the CBP-CREB interaction (CREB inh; 10 μM), and apoptotic cell death was determined by PI-uptake assay. Representative data from repeated experiments performed in triplicate are shown. (PPTX 153 kb)

References

  1. 1.
    Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clin. 2014;64:9–29.CrossRefPubMedGoogle Scholar
  2. 2.
    Martini B. Lung cancer–epidemiology, prognosis and therapy. Med Monatsschr Pharm. 2006;29:217–21.PubMedGoogle Scholar
  3. 3.
    Begg AC, Stewart FA, Vens C. Strategies to improve radiotherapy with targeted drugs. Nat Rev Cancer. 2011;11:239–53.CrossRefPubMedGoogle Scholar
  4. 4.
    Park CM, Park MJ, Kwak HJ, Lee HC, Kim MS, Lee SH, et al. Ionizing radiation enhances matrix metalloproteinase-2 secretion and invasion of glioma cells through Src/epidermal growth factor receptor-mediated p38/Akt and phosphatidylinositol 3-kinase/Akt signaling pathways. Cancer Res. 2006;66:8511–9.CrossRefPubMedGoogle Scholar
  5. 5.
    Cheng JC, Chou CH, Kuo ML, Hsieh CY. Radiation-enhanced hepatocellular carcinoma cell invasion with MMP-9 expression through PI3K/Akt/NF-kappaB signal transduction pathway. Oncogene. 2006;25:7009–18.CrossRefPubMedGoogle Scholar
  6. 6.
    Ho JN, Kang GY, Lee SS, Kim J, Bae IH, Hwang SG, et al. Bcl-XL and STAT3 mediate malignant actions of gamma-irradiation in lung cancer cells. Cancer Sci. 2010;101:1417–23.CrossRefPubMedGoogle Scholar
  7. 7.
    Ebos JM. Prodding the beast: assessing the impact of treatment-induced metastasis. Cancer Res. 2015;75:3417–35.CrossRefGoogle Scholar
  8. 8.
    Katz D, Ito E, Liu FF. On the path to seeking novel radio-sensitizers. Int J Radiat Oncol Biol Phys. 2009;73:988–96.CrossRefPubMedGoogle Scholar
  9. 9.
    Choi JY, Cho HJ, Hwang SG, Kim WJ, Kim JI, Um HD, et al. Podophyllotoxin acetate enhances γ-ionizing radiation-induced apoptotic cell death by stimulating the ROS/p38/caspase pathway. Biomed Pharmacother. 2015;70:111–8.CrossRefPubMedGoogle Scholar
  10. 10.
    Guerram M, Jiang Z-Z, Zhang L-Y. Podophyllotoxin, a medicinal agent of plant origin: past, present and future. Chin J Nat Med. 2012;10:161–9.CrossRefGoogle Scholar
  11. 11.
    Park JK, Jung HY, Park SH, Kang SY, Yi MR, Um HD, et al. Combination of PTEN and gamma-ionizing radiation enhances cell death and G(2)/M arrest through regulation of AKT activity and p21 induction in non-small-cell lung cancer cells. Int J Radiat Oncol Biol Phys. 2008;70:1552–60.CrossRefPubMedGoogle Scholar
  12. 12.
    Park JK, Park SH, So K, Bae IH, Yoo YD, Um HD. ICAM-3 enhances the migratory and invasive potential of human non-small cell lung cancer cells by inducing MMP-2 and MMP-9 via Akt and CREB. Int J Oncol. 2010;36:181–92.PubMedGoogle Scholar
  13. 13.
    Ahn KC, Choi JY, Kim JS, Hwang SG, Kim WJ, Park JK, et al. ICAM-3 endows anticancer drug resistance against microtubule-damaging agents via activation of the ICAM-3-AKT/ERK-CREB-2 pathway and blockage of apoptosis. Biochem Biophys Res Commun. 2013;441:507–13.CrossRefPubMedGoogle Scholar
  14. 14.
    Choi JY, Hong WG, Cho JH, Kim EM, Kim J, Jung CH, et al. Podophyllotoxin acetate triggers anticancer effects against non-small cell lung cancer cells by promoting cell death via cell cycle arrest, ER stress and autophagy. Int J Oncol. 2015;47:1257–65.PubMedPubMedCentralGoogle Scholar
  15. 15.
    Mayr BM, Montminy MR. Transcriptional regulation by the phosphorylation-dependent factor CREB. Nat Rev Mol Cell Biol. 2001;2:599–609.CrossRefPubMedGoogle Scholar
  16. 16.
    Mayr BM, Canettieri G, Montminy MR. Distinct effects of cAMP and mitogenic signals on CREB-binding protein recruitment impart specificity to target gene activation via CREB. Proc Natl Acad Sci U S A. 2001;98:10936–41.CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Alexander S, Friedl P. Cancer invasion and resistance: interconnected processes of disease progression and therapy failure. Trends Mol Med. 2012;18:13–26.CrossRefPubMedGoogle Scholar
  18. 18.
    Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144:646–74.CrossRefPubMedGoogle Scholar
  19. 19.
    Egeblad M, Nakasone ES, Werb Z. Tumors as organs: complex tissues that interface with the entire organism. Dev Cell. 2010;18:884–901.CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Quail DF, Joyce JA. Microenvironmental regulation of tumor progression and metastasis. Nat Med. 2013;19:1423–37.CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    McMillin DW, Negri JM, Mitsiades CS. The role of tumour–stromal interactions in modifying drug response: challenges and opportunities. Nat Rev Drug Discov. 2013;12:217–28.CrossRefPubMedGoogle Scholar
  22. 22.
    Correia AL, Bissell MJ. The tumor microenvironment is a dominant force in multidrug resistance. Drug Resist Updat. 2012;15:39–49.CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Thompson RF, Maity A. Radiotherapy and the tumor microenvironment: mutual influence and clinical implications. Adv Exp Med Biol. 2014;772:147–65.CrossRefPubMedGoogle Scholar
  24. 24.
    Kuonen F, Secondini C, Rüegg C. Molecular pathways: emerging pathways mediating growth, invasion, and metastasis of tumors progressing in an irradiated microenvironment. Clin Cancer Res. 2012;18:5196–202.CrossRefPubMedGoogle Scholar
  25. 25.
    Rüegg C, Monnier Y, Kuonen F, Imaizumi N. Radiation-induced modifications of the tumor microenvironment promote metastasis. Bull Cancer. 2011;98:47–57.PubMedGoogle Scholar
  26. 26.
    von Essen CF. Radiation enhancement of metastasis: a review. Clin Exp Metastasis. 1991;9:77–104.CrossRefGoogle Scholar
  27. 27.
    Park JK, Jang SJ, Kang SW, Park S, Hwang SG, Kim WJ, et al. Establishment of animal model for the analysis of cancer cell metastasis during radiotherapy. Radiat Oncol. 2012;7:153.CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    Schmidt-Ullrich RK, Mikkelsen RB, Dent P, Todd DG, Valerie K, Kavanagh BD, et al. Radiation-induced proliferation of the human A431 squamous carcinoma cells is dependent on EGFR tyrosine phosphorylation. Oncogene. 1997;15:1191–7.CrossRefPubMedGoogle Scholar
  29. 29.
    Edwards E, Geng L, Tan J, Donnelly E, Hallahan DE. Phosphatidylinositol 3-Kinase/Akt signaling in the response of vascular endothelium to ionizing radiation. Cancer Res. 2002;62:4671–7.PubMedGoogle Scholar
  30. 30.
    Munshi A, Ramesh R. Mitogen-activated protein kinases and their role in radiation response. Genes Cancer. 2013;4:401–8.CrossRefPubMedPubMedCentralGoogle Scholar
  31. 31.
    Hynes NE, Lane HA. ERBB receptors and cancer: the complexity of targeted inhibitors. Nat Rev Cancer. 2005;5:341–54.CrossRefPubMedGoogle Scholar
  32. 32.
    Mitsudomi T, Yatabe Y. Epidermal growth factor receptor in relation to tumor development: EGFR gene and cancer. FEBS J. 2010;277:301–8.CrossRefPubMedGoogle Scholar
  33. 33.
    Pao W, Chmielecki J. Rational, biologically based treatment of EGFR-mutant non-small-cell lung cancer. Nat Rev Cancer. 2010;10:760–74.CrossRefPubMedPubMedCentralGoogle Scholar
  34. 34.
    Normanno N, DeLuca A, Bianco C, Strizzi L, Mancino M, Maiello MR, et al. Epidermal growth factor receptor (EGFR) signaling in cancer. Gene. 2006;366:2–16.CrossRefPubMedGoogle Scholar
  35. 35.
    Bode JG, Ehlting C, Häussinger D. The macrophage response towards LPS and its control through the p38(MAPK)-STAT3 axis. Cell Signal. 2012;24:1185–94.CrossRefPubMedGoogle Scholar
  36. 36.
    Wierenga AT, Vogelzang I, Eggen BJ, Vellenga E. Erythropoietin-induced serine 727 phosphorylation of STAT3 in erythroid cells is mediated by a MEK-, ERK-, and MSK1-dependent pathway. Exp Hematol. 2003;31:398–405.CrossRefPubMedGoogle Scholar
  37. 37.
    Amorino GP, Hamilton VM, Valerie K, Dent P, Lammering G, Schmidt-Ullrich RK. Epidermal growth factor receptor dependence of radiation-induced transcription factor activation in human breast carcinoma cells. Mol Biol Cell. 2002;13:2233–44.CrossRefPubMedPubMedCentralGoogle Scholar
  38. 38.
    Matsumoto K, Yamamoto T, Kurachi H, Nishio Y, Takeda T, Homma H, et al. Human chorionic gonadotropin-alpha gene is transcriptionally activated by epidermal growth factor through cAMP response element in trophoblast cells. J Biol Chem. 1998;273:7800–6.CrossRefPubMedGoogle Scholar
  39. 39.
    Swarthout JT, Tyson DR, Jefcoat Jr SC, Partridge NC. Induction of transcriptional activity of the cyclic adenosine monophosphate response element binding protein by parathyroid hormone and epidermal growth factor in osteoblastic cells. J Bone Miner Res. 2002;17:1401–7.CrossRefPubMedGoogle Scholar

Copyright information

© International Society of Oncology and BioMarkers (ISOBM) 2015

Authors and Affiliations

  • Jeong Hyun Cho
    • 1
    • 2
  • Wan Gi Hong
    • 1
  • Yu-Jin Jung
    • 2
  • Jaeseok Lee
    • 3
  • Eunah Lee
    • 4
  • Sang-Gu Hwang
    • 1
  • Hong-Duck Um
    • 1
  • Jong Kuk Park
    • 1
  1. 1.Department of Radiation Cancer ResearchKorea Institute of Radiological and Medical SciencesSeoulSouth Korea
  2. 2.Department of Biological SciencesGangwon National UniversityChuncheon-siSouth Korea
  3. 3.Department of Biological Science, College of Biological ScienceKonkuk UniversitySeoulSouth Korea
  4. 4.Musculoskeletal Bio-Organ Center, College of Life ScienceKyung Hee UniversityYongin-siSouth Korea

Personalised recommendations